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Abstract
The aim of the research is the comparison of professional activity of pharmacists of pharmaceutical institution in Ukraine 
with different education level in relation to their responsibilities in detection and prevention of adverse reactions (AR) or lack of 
efficacy of pharmaceutical products (PP), set out in the regulatory documentation on this matter. 
Materials and methods. The questionnaire was developed and used for pharmacists of pharmaceutical institution, taken 
training on cycles of postgraduate education during 2016–2018. 70 higher education pharmacists (HEPs) and 80 specialized sec-
ondary education pharmacists (SSEP) were inquired. The integrity was evaluated by Fisher’s ratio test (F). For convenience of 
calculation the corresponding functions of MS Excel were used. 
Results. The majority of SSEPs and HEPs of Ukrainian pharmaceutical institutions are aware of their duty to provide in-
formation on AR or lack of efficacy of pharmaceutical products to the Department of Post-authorization Supervision of the State 
Expert Center of the Ministry of Health of Ukraine and are aware of the regulatory legal documentation on this issue, however 
they are not active enough to take necessary action filling in the “Adverse drug reaction reporting form” and sending it to the na-
tional department. One of the reasons for the underactivity of pharmacy workers, irrespective of their level of education, is the low 
organization of this process in pharmacy institutions, in particular the absence of the “Adverse drug reaction reporting forms”. 
Conclusion. Higher education pharmacist are more self-acting in completing “Adverse drug reaction reporting forms” and 
are less likely to shift their responsibilities to the pharmacy manager. It is critical to resolve the issue on enhancement of efficien-
cy of detecting AR and/or lack of efficacy of PP in pharmacy institutions of Ukraine is to improve the quality of organizational 
work of pharmacy managers.
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1. Introduction
The sixties of the XX century are considered the beginning of the history of pharma-
covigilance. It was during the XX World Health Assembly that a decision was made on the 
need to establish an international control system of adverse reactions (AR) to pharmaceutical 
products (PP) [1]. Existing drug monitoring programs are intended to prevent the occurrence of 
AR, as well as to study and minimize medical errors that may occur when taking PP. Adverse 
reactions on PP can be the result of resistance, drug interactions, counterfeiting or their inap-
propriate quality, poisoning, drug dependence, drug abuse, etc. [2]. The vast majority of patient 
security aspects are under the control of the pharmacovigilance system. Spontaneous reports are 
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the main sources of information about AR on drug products [3]. Spontaneous reports of AR or lack 
of efficacy of PP coming from pharmacy practitioners are extremely necessary for future creation 
of recommendations on safety of drugs [4]. According to WHO recommendations [5], a modern 
pharmacist, regardless of his or her level of education (higher or specialized secondary), should be 
able to advise patients and their representatives on problems of healthy lifestyle, as well as on the 
conditions for safe and effective usage of PP that help prevent AR [6].
The main document governing the procedure for collecting and providing information on 
cases of AR and/or lack of efficacy of drugs in Ukraine is the MoH Order of Ukraine No. 898 
(December 27, 2006). According to this order, practitioners of the public health system (medical 
and pharmaceutical) are considered to be the official sources of information on adverse drug 
reactions [6]. Pharmacy practitioners (Higher Education Pharmacists (HEPs) and Specialized Sec-
ondary Education Pharmacists (SSEPs)) must extensively detect AR on drugs and provide the pa-
tient or his/her representative with relevant information on the potentially adverse effects of drugs 
and the causes of AR. They must consult patients on the importance and need to report the occur-
rence of AR and/or lack of efficacy in the application of drugs, as clearly indicated by the current 
“Protocol 1.2. of the pharmaceutical sales representative (pharmacist) when receiving information 
about cases of AR and/or lack of efficacy of PP” [7]. The duties of pharmaceutists also include 
advising a pharmacy shoppers when filling in the form “Adverse drug reaction reporting form to 
provide patients and/or their representative with information on AR and/or lack of efficacy of PP in 
its medical application” (“Adverse drug reaction reporting form”) about the case of AR and/or lack 
of efficacy of PP and inform about the addressee of this information [6].
Workers of pharmacy institutions of Ukraine (both HEPs and SSEPs) take a direct part in 
the care of patients and their representatives. Their direct responsibilities include the ability to 
advise patients on all aspects of the use and safety of drugs. However, the real professional activ-
ity of the workers of Ukrainian pharmaceutical industry on these issues has not been sufficiently 
illustrated in the literature [8–10], and the effectiveness of carrying out their professional duties 
depending on the level of education in the scientific literature has not been shown to date.
The aim of the research is the comparison of professional activity of pharmacists of phar-
maceutical institution of Ukraine with different education level in relation to their responsibilities 
in detection and prevention of AR or lack of efficacy of PP, set out in the regulatory documentation 
on this matter.
2. Materials and methods
The questionnaire was developed and used for pharmacists of pharmaceutical institution, 
taken training on cycles of postgraduate education at the Clinical Pharmacology Department of the 
Institute of Pharmacy Professionals Qualification Improvement (IPHPQI) of National University 
of Pharmacy (Kharkiv) during 2016–2018. Five questions of the questionnaire were aimed at re-
vealing the awareness of practitioners about their responsibility to provide information to the De-
partment of Post-authorisation Supervision of the State Expert Center of the Ministry of Health of 
Ukraine about the AR and/or lack of efficacy of drugs, as well as the ability to fill in “Adverse drug 
reaction reporting form” [6]. As a result of the study, 70 HEPs and 80 SSEPs were questioned. The 
integrity was evaluated by Fisher’s ratio test (F). For convenience of calculation the corresponding 
functions of MS Excel were used.
3. Results 
On the first question: «Do you know about the responsibility of the pharmacist to provide 
information to the Post-authorisation Supervision Department of the “State Expert Center of the 
Ministry of Health of Ukraine” about the AR/lack of efficacy of drugs obtained from pharma-
cy shoppers?», out of 80 SSEPs, 66 (82.5 %) respondents gave positive answer on awareness of 
their responsibilities and 14 (17.5 %) responded negatively (Fig. 1, a). Therefore, among HEPs, 
48 (69 %) respondents answered “yes” and 22 (31 %) answered “no” (Fig. 1, b). The comparison of 
both groups of pharmacy workers is confirmed by the fact that the vast majority of them are well 
aware of their responsibilities in this area, but SSEPs are more aware (p<0.01; F=2.950).
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a                                                                                  b
Fig. 1. Distribution of respondents regarding the answer to the question: «Do you know about the 
responsibility of the pharmacist to provide information to the PaSD of the SEC of MOH about the 
AR/lack of efficacy of drugs obtained from pharmacy shoppers?»: a – SSEPs; b – HEPs
When analyzing the answer to the second poll question: «Specify the correct regulatory 
framework that determines the duty of the pharmaceutical sales representative (pharmacist) to 
provide information about the AR/lack of efficacy of drugs obtained from pharmacy shoppers in 
the PaSD of the SEC of the Ministry of Health» it was found that the correct answer was given by 
60 (75 %) SSEPs (Fig. 2, a). According to these data, 20 (25 %) surveyed SSEPs do not know the 
relevant regulatory framework.
Among HEPs, 52 (74 %) respondents from this group answered the second question cor-
rectly, 16 (23 %) answered incorrectly, 2 (3 %) did not answer this question (Fig. 2, b). There are 
no significant differences on this question between the HEPs group and the SSEPs group (p>0.05; 
F=0.760). This indicates approximately the same level of knowledge of the respondents from both 
groups on this issue.
a                                                                        b
Fig. 2. Distribution of respondents regarding the answer to the question: “Specify the correct 
regulatory framework that determines the duty of the pharmaceutical sales representative 
(pharmacist) to provide information about the AR/lack of efficacy of drugs obtained from 
pharmacy shoppers in the PaSD of the SEC of the Ministry of Health”: a – SSEPs; b – HEPs
Analysis of the third poll questionnaire: “Are there the forms of “Adverse drug reaction 
reporting form” in your pharmacy” – the answer “yes” was given only by 22 (27.5 %) SSEPs, and 
“no” by 58 (72.5 %) (Fig. 3, a). Among the respondents of the HEPs group, 26 (37 %) answered 
“yes” and 44 (63 %) respectively “no” (Fig. 3, b). The obtained data indicate the shortcomings 
concerning the organizational work of the management of a number of pharmacy institutions. Dif-
ferences on this question are significant in the HEPs and SSEPs groups (p<0.01; F=2.291).
The pharmacy institutions in which HEPs work, are better equipped with the necessary 
forms, possibly due to their more demanding attitude to this issue. However, this situation, to a 
greater extent, characterizes only the effectiveness of organizational work, not the professional 
qualities of a pharmacy worker. Probably, the level of education can contribute to greater awareness 
and requirements of employees to the pharmacy management on organizational issues.
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Fig. 3. Distribution of respondents regarding the answer to the question: «Are there the forms of 
“Adverse drug reaction reporting form” in your pharmacy”?: a – SSEPs; b – HEPs
To the fourth question: “How can you send an “Adverse drug reaction reporting form” to the 
PaSD of the SEC of the Ministry of Health?” 20 (25 %) of the SSEPs respondents could not give 
a correct answer (Fig. 4, a), and among HEPs 26 (37 %) of all respondents in this group could not 
answer correctly (Fig. 4, b). This indicates the insufficient information awareness of the regulatory 
framework and a lack of skills in this activity, which contributes to a decrease in data entry on 
AR/lack of efficacy of drugs to the PaSD of the SEC of MOH. Differences on this question in the 
SSEPs and HEPs groups are significant (p<0.01; F=2.698) and the greater number of negative re-
sponses in the HEPs group may indicate that it is the duty to send “Adverse drug reaction reporting 
form” to the pharmacy establishments where the HEPs and SSEPs work together, relying on the 
latter. It also indicates the lack of efficacy of organizational work in pharmaceutical institutions.
a                                                                       b
Fig. 4. Distribution of respondents regarding the answer to the question: “How can you send an 
“Adverse drug reaction reporting form” to the PaSD of the SEC of the Ministry of Health?”:  
a – SSEPs; b – HEPs
When analyzing the answer to the question: “What were your actions when pharmacy vis-
itors reported about AR/lack of efficacy of PP?” it was found that only 10 (12.5 %) of the inter-
viewed SSEPs and 10 (14.3 %) of HEPs (p>0.05; F=0.765) held a consultation on prevention of AR; 
28 (35 %) respondents from SSEPs group and 20 (28.6 %) from HEPs group (p>0.05; F=0.358) 
referred to a doctor for consultation; 2 (2.5 %) respondents from SSEPs group did not respond to the 
information about AR/lack of efficacy of PP, there were none in the HEPs group (p<0.05; F=2.172); 
30 (37.5 %) respondents from SSEP group and (p<0.01; φ=2.898) from HEPs group informed the 
head of the pharmacy institution: 8 (10 %) SSEPs and 20 (28.6 %) HEPs (p<0.01; F=4.058) complet-
ed “Adverse drug reaction reporting form” about AR/lack of efficacy of PP (Fig. 5). 
Thus, the majority of interviewed SSEPs and HEPs responded to patients’ complaints about 
adverse drug reactions, consulted them themselves, or referred them to a doctor. Therefore, there 
were 20 (28.6 %) respondents from the HEPs group who completed the “Adverse drug reaction 
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indicating greater autonomy in the activities of the HEPs on this question. Significantly, the ma-
jority (p<0.01) of the SSEPs group, 30 (37.5 %) transferred their responsibilities to the manager. 
Respondents from the HEPs group were most active in solving problems such as completing the 
Adverse drug reaction reporting form and completing a number of issues on their own without 
transferring their responsibilities to the pharmacy manager.
Fig. 5. Distribution of respondents regarding the answer to the question:  
“If you wrote a report on AR/lack of efficacy of PP, how would you do it?”
4. Discussion
Reporting ARs PP by health care providers is an important component of postmarketing 
drug surveillance. Pharmacists contribute to the drug safety by preventing, identifying, document-
ing and reporting of ARs PP [5, 12]. The role of pharmacist in the department of pharmacovigilance 
varies with different countries but, professionally their responsibility remains the same irrespective 
of the jurisdiction [5, 13–15].
Pharmacists are in a unique position to detect and report ARs PP because of their special-
ized training in pharmaceuticals and widespread use of computers [15]. However, the potential con-
tribution of pharmacists to drug safety through ARs PP reporting is hampered by underreporting, 
which is a major problem [15, 16]. Health care providers in many countries face several obstacles 
when reporting ARs PP to pharmacovigilance centers, including inadequate knowledge of ARs 
and ARs PP reporting, concerns about malpractice litigation, lack of motivation, lack of time, high 
workload, lack of economic incentive, complacency, indifference, ignorance of ARs PP reporting 
requirements, and negative attitudes among others[15, 17–20].
Our research is relevant because the real professional activity of the workers of Ukrainian 
pharmaceutical institutions on these issues has not been sufficiently illustrated in the literature [8–10], 
and the effectiveness of carrying out their professional duties depending on the level of education 
in the scientific literature has not been shown to date.
The conducted questionnaire survey made it possible to conclude that the majority of the 
surveyed HEPs and SSEPs of pharmacy institutions are aware of information about their duties to 
provide information to the PaSD of the SEC of the Ministry of Health about the AR/lack of efficacy 
of drugs and know the regulatory framework regulating the procedure of provision of these com-
munications. The presence of many respondents who are not sufficiently active in performance of 
their duties in this regard in both the HEPs and the SSEPs groups can be largely attributed to the 
low level of organization of this process in pharmacy institutions.
The results are consistent with data from researchers from other countries, who found that 
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Green E. С. [21] reported that encouragement from managers and departments will improve report-
ing. However, due to commercial pressure in pharmacy practice and large volumes of prescriptions, 
the ARs PP report cannot give priority to employers and managers. Therefore, employers and 
managers should be sensitive to the importance of pharmacovigilance and encouraged to support 
pharmacists in their efforts to report ARs PP.
It was found that educational level can increase the awareness and demand of pharmacists 
to their managers on organizational issues. HEPs are more self-acting in completing “Adverse drug 
reaction reporting form” and are less likely to shift their responsibilities to the pharmacy manager.
Study limitations. The following study limitations should be considered in interpreting the 
results. First, the sample size was insufficient (representatives of pharmacy institutes were from 
most (but not all) regions of the country). Second, all respondents were participants of the educa-
tional process at the department, which could affect their answers.
Prospects for further research. More research using larger samples should be conducted 
to confirm this study’s findings. Future research should quantify the extent to which factors influ-
ence pharmacist ARs PP reporting activity. Further, future studies should identify interventions to 
address the barriers and thereby improve ARs PP reporting by pharmacists.
5. Conclusions
1. The majority of HEPs and SSEPs in pharmacy institutions of Ukraine are aware of their 
responsibility to inform about AR/lack of efficacy of PP to the Department of Post-authorization 
Supervision of the “State Expert Center of the Ministry of Health of Ukraine” and are aware of 
information on regulatory documentation on this matter, however, they are not sufficiently active 
to perform necessary actions to complete the “Adverse drug reaction reporting form” and send it to 
the national department. One of the reasons for the lack of activity of pharmacy workers, irrespec-
tive of their level of education, is the low organization in pharmacy institutions, in particular the 
absence of the “Adverse drug reaction reporting forms”.
2. Educational level can increase the awareness and demand of pharmacists to their manag-
ers on organizational issues.
3. Higher education pharmacists are more self-acting in completing “Adverse drug reaction 
reporting form” and are less likely to shift their responsibilities to the pharmacy manager.
4. In order to decide the issue of improvement of efficiency on detecting AR/lack of effi-
cacy of PP in Ukrainian pharmacy, in particular, reducing the dangerous effects of medicines and 
improving the quality of medical care to the population of Ukraine, it is very important not only 
to provide the ongoing education of pharmacists, but also to improve the organizational work of 
pharmacy managers.
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